Related cases:
- CAS 2009_A_1931 Ekaterina Iourieva & Albina Akhatova vs IBU
November 12, 2009 - IBU 2009 IBU vs Ekaterina Iourieva
August 11, 2009 - IBU 2013 IBU vs Ekaterina Iourieva
July 14, 2014 - Swiss Federal Court 4A_620_2009 Ekaterina Iourieva & Albina Akhatova vs IBU
May 7, 2010
On 11 August 2009 the IBU Anti-Doping Hearing Panel (ADHP) decided to impose a 2 year period of ineligibility on the Russian Athlete Ekaterina Iourieva after she tested positive for the prohibited substance recombinant human erythropoietin (rhEPO).
Thereupon in 2014 the Athletes samples - provided in December 2013 and in January 2014 - again tested positive for rhEPO. Consequently on 14 July 2014 the ADHP decided to impose a 8 year period of ineligibility for her second anti-doping violation.
In November 2014 the accredited laboratory in Cologne re-analysed the Athlete samples - provided in November 2013 - and the analysis revealed the presence of rhEPO. The IBU notified the Athlete about this new anti-doping rule violation while she was already serving a 8 year period of ineligibility for her second anti-doping rule violation. The Athlete did not respond to the IBU communication and neither did she attend the hearing of the ADHP.
The IBU requested the ADHP to impose an additional period of ineligibility on the Athlete for her third anti-doping rule violation with consideration of aggravating circumstances due to her previous committed anti-doping rule violations.
The ADHP notes that previously the Athlete had admitted her second anti-doping violation and that this violation was committed at the same time of the second violation. However the ADHP finds that the Athlete did not gave a prompt admission for the anti-doping violation in this case and therefore aggravating circumstances can be taken into account for her use of a prohibited substance on multiple occasions.
Although the ADHP considered the reported violations as one single violation, the ADHP holds that it is a matter of fact that the Athlete provided positive samples at four occasions in a time span of five weeks (November 2013 - January 2014) demonstrating systematic use of EPO.
Therefore without exceptional circumstances the ADHP decides on 30 June 2015 to impose an additional 4 year period of ineligibility on the Athlete starting on the date of expiration of the pending 8 year period of ineligibility, i.e. on 23 December 2021.
